Status:
UNKNOWN
Prostaglandin F2-alpha (PGF2α) in Vitiligo
Lead Sponsor:
Cairo University
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
study the cutaneous expression of PGF2α in vitiligo patients and compare it with normal control subjects.
Detailed Description
Measurement of tissue levels of PGF2α in vitiligo patients and compare them with healthy controls.
Eligibility Criteria
Inclusion
- Patients with non-segmental vitiligo.
- Both sexes.
- Age \< 18 years old.
- New cases or cases not receiving any medications for at least 3 months ago.
Exclusion
- Age: Patients \< 18 years.
- Segmental or universal vitiligo.
- Pregnant and lactating females.
Key Trial Info
Start Date :
December 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03755830
Start Date
December 1 2018
End Date
July 1 2019
Last Update
November 28 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.